Victory Capital Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Buy
169,227
+61,024
+56% +$3.7M 0.01% 1073
2026
Q1
$6M Sell
108,203
-2,380
-2% -$128K ﹤0.01% 1260
2025
Q4
$5.36M Sell
110,583
-93,472
-46% -$3.64M ﹤0.01% 1288
2025
Q3
$6.25M Sell
204,055
-328,030
-62% -$7.53M ﹤0.01% 1257
2025
Q2
$11.8M Buy
532,085
+125,655
+31% +$2.63M 0.01% 1058
2025
Q1
$7.56M Buy
406,430
+71,980
+22% +$1.2M 0.01% 1150
2024
Q4
$4.43M Buy
334,450
+97,200
+41% +$2.35M ﹤0.01% 1294
2024
Q3
$7.95M Buy
237,250
+206,750
+678% +$7.06M 0.01% 1176
2024
Q2
$764K Sell
30,500
-6,180
-17% -$144K ﹤0.01% 1817
2024
Q1
$826K Sell
36,680
-6,460
-15% -$153K ﹤0.01% 1825
2023
Q4
$924K Sell
43,140
-550
-1% -$9.49K ﹤0.01% 1754
2023
Q3
$785K Buy
+43,690
New +$834K ﹤0.01% 1780
2022
Q3
Sell
-16,772
Closed -$340K 2702
2022
Q2
$340K Sell
16,772
-2,572
-13% -$57K ﹤0.01% 2199
2022
Q1
$453K Buy
+19,344
New +$585K ﹤0.01% 2159
2020
Q2
Sell
-3,994
Closed -$56K 2535
2020
Q1
$56K Buy
+3,994
New +$60.6K ﹤0.01% 2492
2019
Q4
Sell
-3,455
Closed -$121K 2658
2019
Q3
$121K Buy
+3,455
New +$164K ﹤0.01% 2380

Other funds holding ANAB

Victory Capital Management's ANAB Position: Q2 2026 in Review

Victory Capital Management increased its AnaptysBio (ANAB) stake by 56% in Q2 2026, buying an estimated $3.7M and bringing the position to 169,227 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #1073.

Victory Capital Management first reported a position in ANAB in Q3 2019 and has held it in 16 quarters since. The position peaked at $11.8M in Q2 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Victory Capital Management held 169,227 shares of AnaptysBio worth $11.4M as of Q2 2026.
  • Victory Capital Management bought 61,024 AnaptysBio shares in Q2 2026, an estimated $3.7M.
  • AnaptysBio made up 0.01% of Victory Capital Management's portfolio in Q2 2026, its #1073 holding.
  • Victory Capital Management first reported a position in AnaptysBio in Q3 2019 and has held it in 16 quarters since.
  • Victory Capital Management's AnaptysBio position peaked at $11.8M in Q2 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.